Lyra to cut 75% of workforce in portfolio shakeup [Seeking Alpha]
Lyra Therapeutics, Inc. (LYRA)
Company Research
Source: Seeking Alpha
Under the program, 87 employees will leave the Watertown, Massachusetts-based pharma as the company ends its manufacturing and commercialization efforts and looks to sublease its facilities. Lyra ( LYRA ) has also paused the development of LYR-220, one of its two late-stage candidates targeted at chronic rhinosinusitis. Instead, the company will focus on its two ongoing late-stage trials for LYR-210, which, however, did not meet its 24-week primary endpoint in its Phase 3 ENLIGHTEN 1 trial early this month. The company said it is evaluating ENLIGHTEN 1 data as it awaits 52-week data from the study in Q4 2024. Additionally, Lyra ( LYRA ) said it is reviewing potential strategic options to maximize shareholder value. More on Lyra Therapeutics Recommended For You More Trending News Recommended For You More Trending News About LYRA Stock Related Stocks Trending Analysis Trending News
Show less
Read more
Impact Snapshot
Event Time:
LYRA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LYRA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LYRA alerts
High impacting Lyra Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
LYRA
News
- Lyra Therapeutics, Inc. (NASDAQ: LYRA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.MarketBeat
- Lyra Therapeutics Announces Cost-Cutting Measures to Preserve Capital [Yahoo! Finance]Yahoo! Finance
- Lyra Therapeutics Announces Cost-Cutting Measures to Preserve CapitalGlobeNewswire
- Lyra Therapeutics, Inc. (NASDAQ: LYRA) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating. They now have a $2.00 price target on the stock, down previously from $12.00.MarketBeat
- Lyra Therapeutics, Inc. (NASDAQ: LYRA) was downgraded by analysts at Bank of America Co. from a "buy" rating to an "underperform" rating.MarketBeat
LYRA
Earnings
- 8/8/23 - Beat
LYRA
Sec Filings
- 6/18/24 - Form 8-K
- 6/14/24 - Form 4
- 6/14/24 - Form 4
- LYRA's page on the SEC website